Skip to main content
# Title Department Research Year
241 Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles Department of Pharmaceutics 2021
242 A novel dual-targeted rosiglitazone-loaded nanoparticle for the prevention of diet-induced obesity via the browning of white adipose tissue Department of Pharmaceutics 2021
243 Betaxolol‐loaded Niosomes Integrated Within pH‐sensitive in situ Forming
Gel for Management of Glaucoma
Department of Pharmaceutics 2021
244 Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia 2021
245 Ivermectin detection using Ag@ B, S co-doped reduced graphene oxide nanohybrid Department of Pharmaceutical Analytical Chemistry 2021
246 Towards understanding of the interaction of certain carbapenems with protein via combined experimental and theoretical approach Department of Pharmaceutical Analytical Chemistry 2021
247 Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity Department of Pharmaceutical Organic Chemistry 2021
248 Colorimetric and fluorometric nanoprobe for selective and sensitive recognition of hazardous colorant indigo carmine in beverages based on ion pairing with nitrogen doped carbon dots Department of Pharmaceutical Analytical Chemistry 2021
249 Novel 2-Indolinone Based derivatives Targeting Cell Cycle Checkpoint’s Proteins as Potential Anticancer Agents Department of Medicinal Chemistry 2021
250 Novel Urea Linked Ciprofloxacin-Chalcone Hybrids having Antiproliferative Topoisomerases I/II Inhibitory Activities and Caspases-Mediated Apoptosis Department of Pharmaceutical Organic Chemistry 2021